We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GRTS market cap is 65.1M. The company's latest EPS is USD -1.2756 and P/E is -0.45.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.44M | 1.95M | 1.56M | 10.38M | 1.74M |
| Operating Income | -34.82M | -35.75M | -34.9M | -30.47M | -39.8M |
| Net Income | -33.98M | -35.26M | -38.43M | -30.82M | -40.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.37M | 4.04M | 48.21M | 19.95M | 16.34M |
| Operating Income | -97.94M | -106.02M | -75.21M | -120.43M | -139.62M |
| Net Income | -94.43M | -105.31M | -75.08M | -119.69M | -138.49M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 209.95M | 222.62M | 187.22M | 177.77M | 137.21M |
| Total Liabilities | 69.07M | 113.06M | 113.24M | 125.92M | 123.25M |
| Total Equity | 140.88M | 109.57M | 73.98M | 51.85M | 13.96M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 184.39M | 221.57M | 278.11M | 240.75M | 177.77M |
| Total Liabilities | 50.05M | 54.83M | 62.02M | 69.97M | 125.92M |
| Total Equity | 134.34M | 166.74M | 216.09M | 170.78M | 51.85M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -40.09M | -71.05M | -102.14M | -121.65M | -33.57M |
| Investing | 21.17M | 45.77M | 64.05M | 102.34M | 12.3M |
| Financing | 8.65M | 9.66M | 9.4M | 25.12M | -379k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -85.01M | -89.1M | -50.68M | -115.95M | -121.65M |
| Investing | 15.84M | 65.95M | -118.55M | -12.96M | 102.34M |
| Financing | 74.4M | 135.8M | 108.76M | 83.1M | 25.12M |
| Market Cap | 65.1M |
| Price to Earnings Ratio | -0.45 |
| Price to Sales Ratio | 3.85 |
| Price to Cash Ratio | 1 |
| Price to Book Ratio | 1.21 |
| Dividend Yield | - |
| Shares Outstanding | 108.57M |
| Average Volume (1 week) | 4.6M |
| Average Volume (1 Month) | 1.76M |
| 52 Week Change | -69.87% |
| 52 Week High | 3.33 |
| 52 Week Low | 0.52 |
| Spread (Intraday) | 0.01 (1.49%) |
| Company Name | Gritstone bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.gritstonebio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
